CoChat

A Disalicylic Acid‐Furanyl Derivative Inhibits Ephrin Binding to a Subset of Eph Receptors

Open access
Noberini, Roberta, De, Surya K., Zhang, Ziming, Wu, Bainan, Raveendra‐Panickar, Dhanya, Chen, Vida, Vazquez, Jesus, Qin, Haina, Song, Jianxing, Cosford, Nicholas D. P., Pellecchia, Maurizio, Pasquale, Elena B. · 2011 · Chemical Biology & Drug Design
Cited by 41

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Eph receptor tyrosine kinases and ephrin ligands control many physiological and pathological processes, and molecules interfering with their interaction are useful probes to elucidate their complex biological functions. Moreover, targeting Eph receptors might enable new strategies to inhibit cancer progression and pathological angiogenesis as well as promote nerve regeneration. Because our previous work suggested the importance of the salicylic acid group in antagonistic small molecules targeting Eph receptors, we screened a series of salicylic acid derivatives to identify novel Eph receptor antagonists. This identified a disalicylic acid‐furanyl derivative that inhibits ephrin‐A5 binding to EphA4 with an IC 50 of 3 μ m in ELISAs. This compound, which appears to bind to the ephrin‐binding pocket of EphA4, also targets several other Eph receptors. Furthermore, it inhibits EphA2 and EphA4 tyrosine phosphorylation in cells stimulated with ephrin while not affecting phosphorylation of EphB2, which is not a target receptor. In endothelial cells, the disalicylic acid‐furanyl derivative inhibits EphA2 phosphorylation in response to TNFα and capillary‐like tube formation on Matrigel, two effects that depend on EphA2 interaction with endogenous ephrin‐A1. These findings suggest that salicylic acid derivatives could be used as starting points to design new small molecule antagonists of Eph receptors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1747-0285.2011.01199.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 41

Metadata

Authors
Noberini, R., De, S. K., Zhang, Z., Wu, B., Raveendra‐Panickar, D., Chen, V., Vazquez, J., Qin, H., Song, J., Cosford, N. D. P., Pellecchia, M., & Pasquale, E. B.
Venue
Chemical Biology & Drug Design
Publisher
Wiley
Published
2011-09-06
Volume
78
Issue
4
Pages
667-678
ISSN
  • 1747-0277 (ISSN-L)
  • 1747-0285
OpenAlex
W1933663256
Cited by
41
References
2
FWCI
2.38
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Disalicylic Acid‐Furanyl Derivative Inhibits Ephrin Binding to a Subset of Eph Receptors. https://app.cochat.ai/papers/10.1111/j.1747-0285.2011.01199.x
The paper
Noberini, R., De, S. K., Zhang, Z., Wu, B., Raveendra‐Panickar, D., Chen, V., Vazquez, J., Qin, H., Song, J., Cosford, N. D. P., Pellecchia, M., & Pasquale, E. B. (2011). A Disalicylic Acid‐Furanyl Derivative Inhibits Ephrin Binding to a Subset of Eph Receptors. Chemical Biology & Drug Design. https://doi.org/10.1111/j.1747-0285.2011.01199.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.